4//SEC Filing
Marhofer John A Jr 4
Accession 0001144204-11-016387
CIK 0001318641other
Filed
Mar 21, 8:00 PM ET
Accepted
Mar 22, 4:40 PM ET
Size
11.3 KB
Accession
0001144204-11-016387
Insider Transaction Report
Form 4
Marhofer John A Jr
Chief Financial Officer
Transactions
- Award
Employee Stock Options (Right to Buy)
2011-03-21+149,609→ 149,609 totalExercise: $7.16From: 2011-03-21Exp: 2021-03-20→ Common Stock (149,609 underlying)
Holdings
- 105,000
Employee Stock Options (Right to Buy)
Exercise: $3.44From: 2010-05-18Exp: 2020-05-17→ Common Stock (105,000 underlying) - 23,184
Employee Stock Options (Right to Buy)
Exercise: $0.67From: 2005-07-01Exp: 2015-06-30→ Common Stock (23,184 underlying) - 20,000
Employee Stock Options (Right to Buy)
Exercise: $4.50From: 2006-03-01Exp: 2016-02-28→ Common Stock (20,000 underlying) - 25,000
Employee Stock Options (Right to Buy)
Exercise: $8.36From: 2007-04-06Exp: 2017-04-05→ Common Stock (25,000 underlying) - 91,500
Employee Stock Options (Right to Buy)
Exercise: $4.00From: 2008-02-04Exp: 2018-02-03→ Common Stock (91,500 underlying)
Footnotes (1)
- [F1]On March 21, 2011, with the approval of the Compensation Committee, Cleveland BioLabs, Inc. issued stock options to Mr. Marhofer per the 2010 Executive Compensation Plan.
Documents
Issuer
CLEVELAND BIOLABS INC
CIK 0001318641
Entity typeother
Related Parties
1- filerCIK 0001370085
Filing Metadata
- Form type
- 4
- Filed
- Mar 21, 8:00 PM ET
- Accepted
- Mar 22, 4:40 PM ET
- Size
- 11.3 KB